
    
      This study is a prospective, multicenter, non-randomized single-arm clinical study to
      evaluate the safety and efficacy of the VIABAHN BX for the treatment of arterial occlusive
      disease in patients with de novo or restenotic lesions in the common and/or external iliac
      arteries.
    
  